Ignite Creation Date:
2024-05-05 @ 4:53 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00338078
Status:
COMPLETED
Last Update Posted:
2008-07-02
First Post:
2006-06-16
Brief Title:
Nocturnal Oxygen Treatment in Heart Failure and Cheyne-Stokes Respiration
Sponsor:
Umeå University
Organization:
Umeå University
Study Overview
Official Title:
Nocturnal Oxygen Treatment in Heart Failure and Cheyne-Stokes Respiration A Randomized Double-Blind Placebo Controlled Cross-Over Study
Status:
COMPLETED
Status Verified Date:
2008-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether oxygen therapy during sleep improves quality of life exercise capacity and heart function among patients with chronic heart failure and central sleep apnea
Detailed Description:
Oxygen therapy reduces the number of central apneas among patients with congestive heart failure but it is unknown whether quality of life and heart function also improve We aim to test whether the quality of life exercise capacity and heart function are improved with nocturnal oxygen therapy during 6 weeks with nocturnal oxygen from oxygen concentrator or nocturnal air from placebo concentrator
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None